---
title: "Lu Pengqi, Deputy Director of the National Intellectual Property Administration, met with the Chairman of the Board of Roche Group from Switzerland"
description: "Lu Pengqi, Deputy Director of the China National Intellectual Property Administration, recently met with Christoph Franz, Chairman of the Board of Roche Group, emphasizing the importance of intellectu"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/261886739.md"
published_at: "2025-10-20T12:37:40.000Z"
---

# Lu Pengqi, Deputy Director of the National Intellectual Property Administration, met with the Chairman of the Board of Roche Group from Switzerland

> Lu Pengqi, Deputy Director of the China National Intellectual Property Administration, recently met with Christoph Franz, Chairman of the Board of Roche Group, emphasizing the importance of intellectual property protection for the business environment and committing to equal protection for both domestic and foreign enterprises. Franz pointed out that intellectual property is the core competitiveness of innovative pharmaceutical companies, and Roche will increase its R&D investment in China to promote the globalization of local pharmaceutical innovation achievements

Recently, Lu Pengqi, Deputy Director of the China National Intellectual Property Administration, met with a visiting delegation led by Severin Schwan, Chairman of the Board of Roche Group, in Beijing. Lu Pengqi stated that in recent years, intellectual property protection has increasingly attracted the attention of both domestic and foreign enterprises as an important aspect of the business environment. The China National Intellectual Property Administration has always adhered to equal protection of intellectual property rights for both domestic and foreign-funded enterprises, effectively safeguarding the legitimate rights and interests of foreign investors. In the future, the China National Intellectual Property Administration will continue to maintain a proactive and open attitude, keeping good communication with rights holders and stakeholders from various countries. Schwan expressed that intellectual property is the core competitiveness for the survival and development of innovative pharmaceutical companies. Supported by China's continuously improving intellectual property protection system, more and more multinational pharmaceutical companies are confident in the Chinese market and are deepening their localization strategies. Roche Group will continue to expand its R&D investment in China and actively promote the benefits of pharmaceutical innovations originating from China to the world

### Related Stocks

- [RHHBY.US - Roche](https://longbridge.com/en/quote/RHHBY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 羅氏報告 2025 財年歸屬淨收入和銷售額增長 | 羅氏報告 FY25 可歸屬淨收入和銷售額增長 | [Link](https://longbridge.com/en/news/274100655.md) |
| 美國防部考慮終止與 Anthropic 合作 旗下 AI 模型模型曾用於生擒馬杜羅 | 美軍利用初創公司 Anthropic 的 AI 工具 Claude 協助捕獲前總統馬杜羅，引發爭議。美國國防部考慮終止與 Anthropic 的合作，因其拒絕放寬 AI 模型使用限制。五角大樓要求 AI 公司允許軍方將工具用於武器研發和戰場 | [Link](https://longbridge.com/en/news/276089881.md) |
| 網易上季經調整純利少賺 27% 遜預期《燕雲十六聲》推動遊戲增長 ADR 盤前跌 5% | 網易 2025 年第四季淨收入 275 億元，按年升 3%，但非公認會計準則純利 71 億元，按年跌 26.8%，遜於預期。遊戲收入增 3.8%，但按季跌 5.6%。CEO 丁磊表示，AI 已成為公司研發核心，提升生產效率並創新遊戲玩法。網 | [Link](https://longbridge.com/en/news/275584370.md) |
| 幣價大跌不用慌？特朗普家族加密貨幣平台海湖莊園辦大會，華爾街態度轉向 | 本週三的海湖莊園活動期間，昔日懷疑加密貨幣的高盛 CEO 蘇德巍透露，他本人持有數量非常有限的比特幣。曾稱比特幣是干擾的富蘭克林鄧普頓 CEO 稱，設想加密貨幣公司與傳統金融機構能攜手合作。特朗普的長子稱去年其家族推出的穩定幣將保護美元霸權 | [Link](https://longbridge.com/en/news/276380974.md) |
| Newamsterdam Pharma｜8-K：2025 財年營收 22.5 百萬美元 |  | [Link](https://longbridge.com/en/news/276224188.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
